Evidence map›Paper›PMID 33971952›Full record

ArticleGenome medicine2021

Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis.

Sunny Z Wu, Daniel L Roden, Ghamdan Al-Eryani, Nenad Bartonicek, Kate Harvey, Aurélie S Cazet, Chia-Ling Chan, Simon Junankar, Mun N Hui, Ewan A Millar and 16 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Loss of STARD7 Triggers Metabolic Reprogramming and Cell Cycle Arrest in Breast Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Inhibitory CARs fail to protect from immediate T cell cytotoxicity.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 2 countries.

Sunny Z WuThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0002-6153-0449
Daniel L RodenThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Ghamdan Al-EryaniThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Nenad BartonicekThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Kate HarveyThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Aurélie S CazetThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Chia-Ling ChanThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Simon JunankarThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Mun N HuiThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Ewan A MillarNSW Health Pathology, Department of Anatomical Pathology, St George Hospital, Kogarah, NSW, Australia.
Julia BeretovNSW Health Pathology, Department of Anatomical Pathology, St George Hospital, Kogarah, NSW, Australia.
Lisa HorvathThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Anthony M JoshuaThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Phillip StrickerSt Vincent's Hospital, Darlinghurst, NSW, Australia.
James S WilmottMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Camelia QuekMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Georgina V LongMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Sydney, Australia.ORCID 0000-0002-8991-0013
Bertrand Z YeungBioLegend, San Diego, CA, USA.
Davendra SegaraSt Vincent's Hospital, Darlinghurst, NSW, Australia.
Cindy MakChris O'Brien Lifehouse, Camperdown, NSW, Australia.
Sanjay WarrierDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, 2050, Australia.
Joseph E PowellGarvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, Australia.
Sandra O'TooleThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Elgene LimThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Alexander SwarbrickThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. a.swarbrick@garvan.org.au.ORCID 0000-0002-3051-5676
Garvan Institute of Medical Research · AUThe University of Sydney · AUSt Vincent's Hospital Sydney · AUBioLegend (United States) · USCamden and Campbelltown Hospitals · AUChris O’Brien Lifehouse · AUSutherland Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh throughput single-cell RNA sequencing (scRNA-Seq) has emerged as a powerful tool for exploring cellular heterogeneity among complex human cancers. scRNA-Seq studies using fresh human surgical tissue are logistically difficult, preclude histopathological triage of samples, and limit the ability to perform batch processing. This hindrance can often introduce technical biases when integrating patient datasets and increase experimental costs. Although tissue preservation methods have been previously explored to address such issues, it is yet to be examined on complex human tissues, such as solid cancers and on high throughput scRNA-Seq platforms.

methodsUsing the Chromium 10X platform, we sequenced a total of ~ 120,000 cells from fresh and cryopreserved replicates across three primary breast cancers, two primary prostate cancers and a cutaneous melanoma. We performed detailed analyses between cells from each condition to assess the effects of cryopreservation on cellular heterogeneity, cell quality, clustering and the identification of gene ontologies. In addition, we performed single-cell immunophenotyping using CITE-Seq on a single breast cancer sample cryopreserved as solid tissue fragments.

resultsTumour heterogeneity identified from fresh tissues was largely conserved in cryopreserved replicates. We show that sequencing of single cells prepared from cryopreserved tissue fragments or from cryopreserved cell suspensions is comparable to sequenced cells prepared from fresh tissue, with cryopreserved cell suspensions displaying higher correlations with fresh tissue in gene expression. We showed that cryopreservation had minimal impacts on the results of downstream analyses such as biological pathway enrichment. For some tumours, cryopreservation modestly increased cell stress signatures compared to freshly analysed tissue. Further, we demonstrate the advantage of cryopreserving whole-cells for detecting cell-surface proteins using CITE-Seq, which is impossible using other preservation methods such as single nuclei-sequencing.

conclusionsWe show that the viable cryopreservation of human cancers provides high-quality single-cells for multi-omics analysis. Our study guides new experimental designs for tissue biobanking for future clinical single-cell RNA sequencing studies.

Indexed as

Biological Specimen BanksCryopreservationGenomicsSingle-Cell AnalysisBiomarkers, TumorGene Expression ProfilingGene Expression RegulationHigh-Throughput Nucleotide SequencingHumansImmunophenotypingNeoplasmsOrgan SpecificitySequence Analysis, RNASignal TransductionBiomarkers, TumorBreast cancerCITE-SeqCryopreservationMelanomaProstate cancerSingle-cell RNA sequencingTumour heterogeneity

Identifiers

PMID33971952
PMCPMC8111910
OpenAlexW3163788854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.